Egypt wingers Mahmoud “Trezeguet” Hassan and Ibrahim Adel will miss Tuesday’s friendly against Nigeria but they will be fit for the start of the Africa Cup of Nations (AFCON 2025) against Zimbabwe, ...

ADEL-Y01, a monoclonal antibody targeting tau protein, is in Phase I trials for Alzheimer's disease, developed by ADEL and licensed to Sanofi. The ADEL-Sanofi agreement is valued at over $1.04 billion ...

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- ADEL, Inc., a biopharmaceutical company dedicated to developing therapies for neurodegenerative diseases such as Alzheimer's Disease, today announced ...

Three-time winners Nigeria and seven-time champions Egypt will be at each other’s jugular at the Cairo Stadium tonight, in a friendly match meant to prepare both teams for their campaigns at the 35 th ...

Dec 16 (Reuters) - South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with ‌French drugmaker Sanofi to develop and sell the ‌biotech company's experimental ...

Dec 16 (Reuters) - South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi (SASY.PA), opens new tab to develop and sell the biotech ...

Liverpool head coach Arne Slot stated on Friday that he will continue holding talks with disgruntled star Mohamed Salah ahead of Saturday's Premier League match against Brighton. It's unclear whether ...

Adel (ADEL), which is jointly developing an Alzheimer's disease drug candidate with Oscotec, said on the 16th that it signed a technology transfer agreement with French drugmaker Sanofi to transfer ...

CAIRO, Dec 11 - Mohamed Salah will escape the tension at Liverpool for a spell when he heads to Morocco with Egypt next week for the Africa Cup of Nations, following his clash ‍with the Premier League ...

Three-time winners Nigeria and seven-time champions Egypt meet at the Cairo Stadium on Tuesday evening in a friendly designed to fine-tune preparations for the 35th Africa Cup of Nations finals, which ...